Metaphyseal chondrodysplasia, Spahr type

Metaphyseal chondrodysplasia, Spahr type (also known as Spahr-type metaphyseal chondrodysplasia) is an extremely rare inherited skeletal disorder characterized by abnormalities in the growth plates (metaphyses) of long bones. It belongs to the broader group of metaphyseal chondrodysplasias, which are conditions affecting the development of cartilage and bone at the ends of long bones. The condition primarily affects the skeletal system, leading to short-limbed short stature (dwarfism) with bowing of the legs (genu varum), which typically becomes apparent in early childhood when the child begins to walk. The hallmark radiographic features include metaphyseal irregularities, particularly widening and cupping of the metaphyses of long bones, most prominently at the knees. Unlike some other forms of metaphyseal chondrodysplasia, the Spahr type is generally considered a milder variant, and affected individuals may have relatively normal facial features and no significant involvement of other organ systems such as the immune or gastrointestinal systems. Intelligence is typically normal. There is currently no specific cure or targeted therapy for metaphyseal chondrodysplasia, Spahr type. Management is primarily supportive and symptomatic, focusing on orthopedic interventions to address leg bowing and other skeletal deformities. This may include bracing or corrective surgical procedures such as osteotomies when necessary. Regular monitoring of growth and skeletal development by a multidisciplinary team including orthopedic specialists and clinical geneticists is recommended. The condition was originally described in families of Lebanese origin.

Common questions about Metaphyseal chondrodysplasia, Spahr type